- Report
- November 2025
- 197 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 196 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 283 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 268 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 186 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 381 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 192 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 297 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 136 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 169 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 304 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 189 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 194 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 118 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 181 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 285 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 270 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 289 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 384 Pages
Global
From €5256EUR$5,850USD£4,637GBP
- Report
- November 2025
- 274 Pages
Global
From €5256EUR$5,850USD£4,637GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more